Clinical Trials Logo

Vitamin c clinical trials

View clinical trials related to Vitamin c.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05770596 Recruiting - Clinical trials for Post-mastectomy Pain Syndrome

Vitamin C on Acute and Chronic Post Mastectomy Pain

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of perioperative vitamin C on acute and chronic post mastectomy pain after breast cancer surgery

NCT ID: NCT05694975 Recruiting - COVID-19 Pneumonia Clinical Trials

Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients.

Start date: January 13, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The main aim is to determine whether vitamin C can reduce 28-day all-cause mortality or persistent organ dysfunction compared with placebo in patients with severe and critical ill COVID-19 patients. Participants will randomly receive HIVC or placebo for 4 days once enrolled. The primary outcome is a composite of death or persistent organ dysfunction (defined as dependency on vasopressors, mechanical ventilation, or CRRT) at day 28 after randomization.

NCT ID: NCT04516681 Recruiting - Colorectal Cancer Clinical Trials

IV Ascorbic Acid in Peritoneal Metastatic Colorectal Cancer

Start date: September 1, 2020
Phase: Phase 3
Study type: Interventional

Previous preclinical study has shown that high levels of ascorbic acid (AA) possesses the ability to kill human colorectal cancer cells and high expression of GLUT3 will augment the efficacy of AA. To date, no previous studies have investigated the therapeutic role of AA in peritoneal metastatic colorectal cancer with high expression of GLUT3. This protocol is a randomized controlled study of AA infusions combined with FOLFOXIRI +/- bevacizumab versus treatment with FOLFOXIRI +/- bevacizumab alone in peritoneal metastatic colorectal cancer patients with high expression of GLUT3.